Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Jitongning Pian for axial spondyloarthritis (kidney yang deficiency, blood stasis) – phase III randomized double-blind placebo-controlled trial
CTR20231190Phase 3Active
- Sponsor
- Tasly Pharmaceutical Group Co., Ltd.
- Start
- Sep 2023
- Countries
- 1
01
Overview
A Phase 3 trial of jitongning in axial spondyloarthritis (axSpA), sponsored by Tasly Pharmaceutical Group Co., Ltd.. Started Sep 2023; status: active.
02
Drugs
jitongning
03
Conditions
axial spondyloarthritis (axSpA)
Beyond the preview
Go deeper on CTR20231190.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20231190.